These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 887495)

  • 1. [Effect of vitamin C on heparin activity in patients with chronic renal failure treated with hemodiaglysis].
    Chmielewska J; Poplawski A
    Pol Tyg Lek; 1977 Jul; 32(28):1079-80. PubMed ID: 887495
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation.
    Böhm V; Tiroke K; Schneider S; Sperschneider H; Stein G; Bitsch R
    Int J Vitam Nutr Res; 1997; 67(4):262-6. PubMed ID: 9285256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of heparin on lipid metabolism in patients with chronic renal failure treated with hemodialysis].
    Chmielewska J; Poplawski A
    Pol Tyg Lek; 1977 Aug; 32(34):1337-40. PubMed ID: 905179
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of vitamin C on heparin activity.
    Poplawski A
    Acta Physiol Pol; 1973; 24(6):877-82. PubMed ID: 4765593
    [No Abstract]   [Full Text] [Related]  

  • 5. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein oxidation profile in end stage renal disease patients. Role of vitamin C supplementation].
    Ramos R; Gómez-Geriqué N; Martínez-Castelao A
    Nefrologia; 2005; 25(2):178-84. PubMed ID: 15912655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction and oxidative stress in chronic renal failure.
    Ghiadoni L; Cupisti A; Huang Y; Mattei P; Cardinal H; Favilla S; Rindi P; Barsotti G; Taddei S; Salvetti A
    J Nephrol; 2004; 17(4):512-9. PubMed ID: 15372412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoperoxidation and hemodialysis.
    Ramos R; Martínez-Castelao A
    Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of furosemide on urinary excretion of oxalic acid, vitamin C and vitamin B6 in chronic kidney failure].
    Mydlík M; Derzsiová K; Zemberová E; Rajnic A
    Vnitr Lek; 1998 Mar; 44(3):127-31. PubMed ID: 9820088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The excretion of ascorbic acid and its metabolites in uremia and hemodialysis].
    Bakaev VV; Efremov AV
    Patol Fiziol Eksp Ter; 2000; (2):22-4. PubMed ID: 10846906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Haemodialysis in children (author's transl)].
    Wolf A; Balzar E; Pinggera WF; Stummvoll HK
    Wien Klin Wochenschr; 1980 Jan; 92(2):35-42. PubMed ID: 6990630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients.
    Fumeron C; Nguyen-Khoa T; Saltiel C; Kebede M; Buisson C; Drüeke TB; Lacour B; Massy ZA
    Nephrol Dial Transplant; 2005 Sep; 20(9):1874-9. PubMed ID: 15972322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
    Kuźniewski M; Sułowicz W
    Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneal dialysis in the treatment of chronic renal failure].
    Kazimirov VG; Butrin SV; Bekov RR; Sapozhnikov AD; Kharitonov BI; Smoliakov AM; Detinenko IN
    Urologiia; 2004; (5):58-62. PubMed ID: 15560166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidation in hemodialysis patients: effect of vitamin C supplementation.
    Ferretti G; Bacchetti T; Masciangelo S; Pallotta G
    Clin Biochem; 2008 Apr; 41(6):381-6. PubMed ID: 18194672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arterial hypertension in chronic kidney failure treated by extra-renal dialysis].
    Traeger J; Zech P; François B; Heydendael G; Moskovtchenko JF; Dubois Y; Pozet N; Sassard J
    Acquis Med Recent; 1969; ():261-96. PubMed ID: 5376775
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemolytic anemia in chronically dialyzed patients induced by free chlorine in tap water (author's transl)].
    Kawaguchi S
    Nihon Jinzo Gakkai Shi; 1979 Jun; 21(6):567-83. PubMed ID: 226761
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ascorbic acid supplementation on plasma isoprostanes in haemodialysis patients.
    Chan D; Irish A; Croft KD; Dogra G
    Nephrol Dial Transplant; 2006 Jan; 21(1):234-5. PubMed ID: 16204285
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
    Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.